Hot Stocks
|
GitLab, and Oracle… GitLab, and Oracle Corporation announced the general availability of a new offering that expands shared artificial intelligence and machine learning functionalities. Customers can now run AI and ML workloads with GPU-enabled GitLab runners on Oracle Cloud Infrastructure. GitLab strives to meet customers where they are, and this collaboration with OCI provides streamlined access to GitLab runners for Oracle users. Customers benefit from OCI's high performance, built-in security, and distributed cloud capabilities, giving them the flexibility to access and deploy cloud services wherever they need them, including on-premises and multicloud environments. ShowHide Related Items >><< - 04/04/23
- Oracle plans to open a second cloud region in Singapore
- 03/27/23
- Palantir, C3.ai among 18 contractors selected for $900M Space Force contract
- 03/21/23
- Nvidia selects Oracle Cloud Infrastructure for AI services
- 03/21/23
- Nvidia announces availability of new products featuring H100 Tensor Core GPU
- 03/15/23
- GV 2021 GP increases GitLab stake by $19M
- 03/13/23
- GitLab falls 36% to $28.53 after Q4 results and guidance
- 03/02/23
- GitLab increasing list price of GitLab Premium
- 02/09/23
- GitLab drops 5% to $46.90 after job cuts, MoffettNathanson comments
- 03/29/23 SMBC Nikko
- GitLab initiated with a Neutral at SMBC Nikko
- 03/28/23 Mizuho
- GitLab initiated with a Neutral at Mizuho
- 03/15/23 Barclays
- GitLab price target lowered to $45 from $65 at Barclays
- 03/14/23 UBS
- GitLab price target lowered to $35 from $54 at UBS
- 03/24/23 UBS
- Oracle price target raised to $90 from $87 at UBS
- 03/24/23 JPMorgan
- Oracle demand appears 'somewhat stable,' says JPMorgan
- 03/10/23 Societe Generale
- Oracle downgraded to Hold at Societe Generale on valuation
- 03/10/23 Societe Generale
- Oracle downgraded to Hold from Buy at Societe Generale
- 03/09/23
- Oracle sees Q4 EPS $1.56-$1.60, consensus $1.46
- 03/09/23
- Oracle reports Q3 adjusted EPS $1.22, consensus $1.20
- 03/09/23
- Notable companies reporting after market close
- 12/12/22
- Oracle sees Q3 EPS $1.23-$1.27, consensus $1.24
- 03/13/23
- GitLab sees FY24 EPS (29c)-(24c), consensus (52c)
- 03/13/23
- GitLab sees Q1 EPS (15c)-(14c), consensus (16c)
- 03/13/23
- GitLab reports Q4 EPS (3c), consensus (14c)
- 12/05/22
- GitLab sees FY23 EPS (56c)-(54c), consensus (65c)
- 10/24/22
- SAP delays Russia exit as deal discussions fail, Reuters reports
- 03/10/23
- What You Missed On Wall Street On Friday
- 03/10/23
- What You Missed On Wall Street This Morning
- 03/10/23
- Fly Intel: Pre-market Movers
- 03/09/23
- Fly Intel: After-Hours Movers
- 04/02/23
- Sell these stocks now, proven algorithm says
- 03/24/23
- Sell these stocks now, proven algorithm says
- 03/14/23
- What You Missed On Wall Street On Tuesday
- 03/14/23
- What You Missed On Wall Street This Morning
- 03/24/23
- Unusually active option classes on open March 24th
- 03/09/23
- Oracle options imply 3.8% move in share price post-earnings
- 02/23/23
- Unusually active option classes on open February 23rd
- 02/13/23
- Unusually active option classes on open February 13th
- 03/20/23
- Gitlab call volume above normal and directionally bullish
- 03/15/23
- Gitlab call volume above normal and directionally bullish
- 03/13/23
- Gitlab options imply 13.0% move in share price post-earnings
- 12/05/22
- Gitlab options imply 15.7% move in share price post-earnings
|
On The Fly
| ShowHide Related Items >><< - 03/14/23
- Take-Two announces availability of WWE 2K23 icon, deluxe editions
- 03/10/23
- Sony says 'Hogwarts Legacy' most downloaded PS5 game in February
- 02/22/23
- Snickers and WWE 2K23 to return as presenting partners at WrestleMania
- 02/17/23
- Take-Two's Firaxis names Hazen studio head, confirms new 'Civilization' coming
- 02/21/23
- Cathie Wood's ARK Investment bought 33.6K shares of Toast today
- 02/16/23
- Toast falls -19.0%
- 02/16/23
- Toast falls -22.5%
- 02/16/23
- Toast falls -18.1%
- 10/24/22
- Sun Communities to increase rental rates in FY23
- 10/04/22
- Sun Communities continues to evaluate impact of Hurrican Ian
- 03/23/23
- Snap unveils AR Enterprise Services
- 03/20/23
- Snap COO sells $763.9K in common stock
- 03/20/23
- Snap CFO sells $539K in common stock
- 03/15/23
- Snap introduces Content Controls for Family Center
- 01/30/23
- GSE Systems announces contract to work with Nuscale Power
- 01/24/23
- Spring Valley Acquisition Corp trading resumes
- 01/24/23
- Spring Valley Acquisition Corp trading halted, volatility trading pause
- 01/04/23
- Nuscale Power, RoPower sign contract for development of SMR plant in Romania
RCKT Rocket Pharmaceuticals - 03/10/23
- Rocket Pharmaceuticals says no cash deposits, securities at SVB
- 02/07/23
- Rocket Pharmaceuticals announces RMAT designation for RP-A501 from FDA
- 01/09/23
- Rocket Pharmaceuticals adds RP-A601, PKP2-ACM to gene therapy portfolio
- 12/22/22
- Rocket Pharmaceuticals provides update on registration path for RP-A501
- 03/01/23
- Peloton appoints Dalana Brand as CPO
- 02/13/23
- Capital World Investors discloses 7.8% stake in Peloton
- 02/01/23
- Peloton not forecasting spike in churn rate
- 02/01/23
- Peloton still sees revenue for the year to resemble seasonality of FY22
- 03/15/23
- GV 2021 GP increases GitLab stake by $19M
- 03/13/23
- GitLab falls 36% to $28.53 after Q4 results and guidance
- 03/02/23
- GitLab increasing list price of GitLab Premium
- 02/09/23
- GitLab drops 5% to $46.90 after job cuts, MoffettNathanson comments
- 01/23/23
- Eve Holding falls -11.7%
- 01/23/23
- Eve Holding falls -11.5%
- 01/23/23
- Eve Holding falls -8.6%
- 12/23/22
- Eve Holding announces BNDES approval for funding of eVTOL development efforts
- 11/14/22
- Elliott made Triple Flag Precious Metals top holding during Q3
- 03/10/23
- Gingko says roughly 6% of cash, cash equivalents held in SVB accounts
- 03/09/23
- Cathie Wood's ARK Investment bought 2.1M shares of Ginkgo Bioworks today
- 03/02/23
- Cathie Wood's ARK Investment bought 2.3M shares of Ginkgo Bioworks today
- 02/16/23
- Ginkgo Bioworks, Zymtronix announce partnership
- 03/27/23
- Cameco to receive refund of $300M from Canada Revenue Agency
- 03/09/23
- Senators forward bill to ban Russian uranium imports
- 02/08/23
- Cameco, Energoatom to supply Ukraine's natural UF6 needs through 2035
- 11/29/22
- Uranium Royalty Cameco to receive royalty proceeds from McArthur River mine
- 03/30/23
- Braze to acquire North Star
- 12/13/22
- Braze falls 6% to $27.16 after Q3 results and guidance
- 10/03/22
- Braze director buys $17M in common stock
- 03/21/23
- Beam Therapeutics names Gopi Shanker, Ph.D., as Chief Scientific Officer
- 01/19/23
- Cathie Wood's ARK Investment bought 52.8K shares of Beam Therapeutics today
- 12/11/22
- Beam Therapeutics announces preclinical data from ESCAPE conditioning approach
- 12/02/22
- Beam Therapeutics jumps 11% to $51.00 after FDA lifts hold on IND for BEAM-201
- 03/14/23
- CEO says AMC 'APE' conversion approved by shareholders
- 03/14/23
- AMC falls after investors approve increase in common shares
- 03/14/23
- AMC Entertainment trading resumes
- 03/14/23
- AMC shares fall 10% amid shareholder votes at special meeting
- 03/27/23
- Palantir, C3.ai among 18 contractors selected for $900M Space Force contract
- 03/06/23
- Kerrisdale Capital short C3.ai on 'poor customer traction,' financial pressures
- 03/03/23
- C3.ai rises 27.5%
- 03/03/23
- C3.ai rises 17.9%
- 03/21/23 JMP Securities
- JMP analysis of Amazon data shows Peloton position strengthening
- 03/10/23 BofA
- ITC decision won't have major impact on Peloton service, sales, says BofA
- 02/02/23 Needham
- Peloton price target raised to $20 from $14 at Needham
- 02/02/23 Roth MKM
- Peloton price target raised to $20 from $13 at Roth Capital
- 03/29/23 Wedbush
- Amazon unlikely to acquire AMC, says Wedbush
- 03/28/23 Raymond James
- EPR has upside if AMC were to be sold, says Raymond James
- 03/23/23 Citi
- AMC Entertainment resumed with a Sell at Citi
- 02/09/23 Macquarie
- Macquarie raises price target on top theatre pick for 2023
- 02/10/23 Canaccord
- Cameco price target raised to C$48 from C$46 at Canaccord
- 02/10/23 Scotiabank
- Cameco price target raised to C$50 from C$43 at Scotiabank
- 02/10/23 Raymond James
- Cameco price target raised to C$48 from C$45 at Raymond James
- 02/10/23 TD Securities
- Cameco upgraded to Action List Buy from Buy at TD Securities
- 03/29/23 Morgan Stanley
- TikTok ban could put 53B U.S. consumer hours 'up for grabs,' says Morgan Stanley
- 03/27/23 Guggenheim
- Snap price target raised to $12 from $9 at Guggenheim
- 03/16/23 Benchmark
- Benchmark sees low odds of any formal TikTok ban in U.S. through 2024
- 03/09/23 Piper Sandler
- Piper says TikTok ownership change would have negligible value impact on peers
- 03/21/23 Bernstein
- Beam Therapeutics initiated with a Market Perform at Bernstein
- 03/10/23 Stifel
- Stifel says SVB fallout 'appears limited' across firm's biotech coverage
- 03/01/23 Wells Fargo
- Beam Therapeutics price target lowered to $105 from $125 at Wells Fargo
- 02/01/23 Cantor Fitzgerald
- Beam Therapeutics initiated with an Overweight at Cantor Fitzgerald
- 02/14/23 DZ Bank
- Take-Two downgraded to Hold from Buy at DZ Bank
- 02/08/23 BMO Capital
- Take-Two price target raised to $130 from $120 at BMO Capital
- 02/07/23 Roth MKM
- Take-Two price target lowered to $130 from $140 at Roth MKM
- 02/07/23 Jefferies
- Potential new gaming paradigm favors Take-Two in long run, says Jefferies
- 03/31/23 Canaccord
- Braze price target raised to $38 from $33 at Canaccord
- 03/31/23 BTIG
- Braze price target raised to $40 from $34 at BTIG
- 03/31/23 Oppenheimer
- Braze price target raised to $36 from $30 at Oppenheimer
- 03/17/23 UBS
- Braze downgraded to Neutral from Buy at UBS
- 03/03/23 Barclays
- Diamond Offshore price target lowered to $20 from $21 at Barclays
- 02/16/23 Barclays
- Diamond Offshore initiated with an Overweight at Barclays
- 03/01/23 JPMorgan
- Eve Holding initiated with an Overweight at JPMorgan
- 02/16/23 Cantor Fitzgerald
- Eve Holding initiated with a Neutral at Cantor Fitzgerald
- 12/30/22 Raymond James
- Eve Holding will need capital before certification, says Raymond James
- 07/27/22 Raymond James
- Eve Holding initiated with a Market Perform at Raymond James
RCKT Rocket Pharmaceuticals - 03/01/23 Chardan
- Rocket Pharmaceuticals price target lowered to $63 from $65 at Chardan
- 02/01/23 Morgan Stanley
- Rocket Pharmaceuticals initiated with an Overweight at Morgan Stanley
- 12/23/22 BofA
- Rocket Pharmaceuticals stock reaction looks 'overdone,' says BofA
- 03/29/23 SMBC Nikko
- GitLab initiated with a Neutral at SMBC Nikko
- 03/28/23 Mizuho
- GitLab initiated with a Neutral at Mizuho
- 03/15/23 Barclays
- GitLab price target lowered to $45 from $65 at Barclays
- 03/14/23 UBS
- GitLab price target lowered to $35 from $54 at UBS
- 03/22/23 TD Cowen
- Nuscale Power price target lowered to $14.50 from $17 at TD Cowen
- 10/25/22 UBS
- Nuscale Power initiated with a Neutral at UBS
- 08/25/22 Wells Fargo
- Nuscale Power initiated with an Equal Weight at Wells Fargo
- 08/18/22 Guggenheim
- Guggenheim starts 'unique opportunity' Nuscale Power with Buy, $18 target
- 03/31/23 Truist
- Sun Communities price target lowered to $163 from $166 at Truist
- 03/29/23 Wells Fargo
- Sun Communities initiated with an Equal Weight at Wells Fargo
- 12/01/22 Truist
- Sun Communities price target raised to $163 from $147 at Truist
- 11/30/22 Truist
- Sun Communities price target raised to $163 from $147 at Truist
- 03/03/23 Deutsche Bank
- C3.ai price target raised to $16 from $11 at Deutsche Bank
- 03/03/23 Piper Sandler
- C3.ai price target raised to $23 from $13 at Piper Sandler
- 03/03/23 Canaccord
- C3.ai price target raised to $21 from $14 at Canaccord
- 03/03/23 Wedbush
- C3.ai price target raised to $24 from $13 at Wedbush
- 03/05/23 BTIG
- Ginkgo Bioworks price target lowered to $3 from $4 at BTIG
- 11/28/22 Berenberg
- Berenberg starts 'well-positioned' disruptor Ginkgo Bioworks with a Buy
- 11/28/22 Berenberg
- Ginkgo Bioworks initiated with a Buy at Berenberg
- 10/04/22 Morgan Stanley
- Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley
- 03/23/23 Exane BNP Paribas
- Toast initiated with a Neutral at Exane BNP Paribas
- 02/21/23 DA Davidson
- Toast price target lowered to $25 from $27 at DA Davidson
- 02/17/23 Piper Sandler
- Toast price target raised to $23 from $22 at Piper Sandler
- 02/16/23 SMBC Nikko
- Toast downgraded to Neutral from Outperform at SMBC Nikko
- 02/06/23
- Take-Two sees Q4 GAAP EPS ($1.27)-($1.17), consensus $1.06
- 02/06/23
- Take-Two cuts FY23 net bookings view to $5.2B-$5.25B from $5.4B-$5.5B
- 02/06/23
- Take-Two reports Q3 GAAP EPS (91c), consensus 87c
- 02/06/23
- Notable companies reporting after market close
- 02/16/23
- Toast sees FY23 revenue $3.57B-$3.66B, consensus $3.61B.
- 02/16/23
- Toast sees Q1 revenue $745M-$775M, consensus $751.14M.
- 02/16/23
- Toast reports Q4 EPS (19c), consensus (14c)
- 02/15/23
- Notable companies reporting before tomorrow's open
- 02/22/23
- Sun Communities sees FY23 EPS $2.50-$2.70, consensus $2.87
- 02/22/23
- Sun Communities sees Q1 EPS (3c)-2c, consensus 22c
- 02/22/23
- Sun Communities reports Q4 EPS 4c, consensus 10c
- 10/24/22
- Sun Communities sees Constant Currency Core FFO $1.23-$1.29
- 01/31/23
- Snap sees Q1 revenue down 2%-10% y/y, consensus $1.08B
- 01/31/23
- Snap reports Q4 EPS 14c, consensus 11c
- 01/31/23
- Notable companies reporting after market close
- 10/20/22
- Snap reports Q3 adjusted EPS 8c, consensus (1c)
RCKT Rocket Pharmaceuticals - 02/27/23
- Rocket Pharmaceuticals reports Q4 EPS (92c), consensus (80c)
- 11/03/22
- Rocket Pharmaceuticals reports Q3 EPS (87c), consensus (79c)
- 02/01/23
- Peloton sees Q3 revenue $690M-$715M, consensus $692.14M
- 02/01/23
- Peloton reports Q2 EPS (98c), consensus (64c)
- 01/31/23
- Notable companies reporting before tomorrow's open
- 03/13/23
- GitLab sees FY24 EPS (29c)-(24c), consensus (52c)
- 03/13/23
- GitLab sees Q1 EPS (15c)-(14c), consensus (16c)
- 03/13/23
- GitLab reports Q4 EPS (3c), consensus (14c)
- 12/05/22
- GitLab sees FY23 EPS (56c)-(54c), consensus (65c)
- 02/28/23
- Diamond Offshore reports Q4 EPS (52c), consensus (32c)
- 02/27/23
- Diamond Offshore reports Q4 EPS (52c), consensus (32c)
- 03/01/23
- Ginkgo Bioworks sees 2023 revenue at least $275M, consensus $381.51M
- 03/01/23
- Ginkgo Bioworks reports Q4 EPS (10c), consensus (21c)
- 01/11/23
- Ginkgo Bioworks backs FY22 revenue view $460M-$480M, consensus $470.79M
- 11/14/22
- Ginkgo Bioworks sees FY22 revenue $425M-$440M, consensus $435.34M
- 02/09/23
- Cameco sees 2023 revenue $2.12B-$2.27B, consensus $1.63B
- 02/09/23
- Cameco reports Q4 adjusted EPS 9c, consensus 6c
- 10/27/22
- Cameco reports Q3 adjusted EPS 3c, consensus 2c
- 03/30/23
- Braze sees FY24 EPS (59c) to (55c), consensus (57c)
- 03/30/23
- Braze sees Q1 EPS (19c) to (18c), consensus (17c)
- 03/30/23
- Braze reports Q4 EPS (35c), consensus (19c)
- 12/13/22
- Braze sees FY23 EPS (69c) to (68c), consensus (77c)
- 02/28/23
- Beam Therapeutics reports Q4 EPS (54c), consensus ($1.33)
- 11/07/22
- Beam Therapeutics reports Q3 EPS ($1.56), consensus ($1.31)
- 02/28/23
- AMC Entertainment reports Q4 adjusted EPS (14c), consensus (21c)
- 02/28/23
- Notable companies reporting after market close
- 11/08/22
- AMC Entertainment reports Q3 adjusted EPS (20c), consensus (25c)
- 03/02/23
- C3.ai sees FY23 revenue $264M-$266M, consensus $261.3M
- 03/02/23
- C3.ai sees Q4 revenue $70M-$72M, consensus $69.85M
- 03/02/23
- C3.ai reports Q3 adjusted EPS (6c), consensus (22c)
- 03/02/23
- Notable companies reporting after market close
|